EGFRviii Protein (AA 25-378) (PE,His-Avi Tag)
-
- Antigène Tous les produits EGFRviii (EGFRv3)
- EGFRviii (EGFRv3) (EGFR vIII (EGFRv3))
- Type de proteíne
- Recombinant
- Attributs du protein
- AA 25-378
- Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette EGFRviii protéine est marqué à la PE,His-Avi Tag.
- Fonction
- PE-Labeled Human EGFRVIII Protein
- Séquence
- Leu25-Ser378
- Attributs du produit
- Recombinant PE-Labeled Human EGFRVIII Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Leu25-Ser378.
- Stérilité
- 0.22 μm filtered
- niveau d'endotoxine
- Less than 1EU per μg by the LAL method.
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as 0.22μm filtered solution in PBS ( pH 7.4).
- Stock
- -80 °C
- Stockage commentaire
- Valid for 6 months from date of receipt when stored at -80°C., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- EGFRviii (EGFRv3) (EGFR vIII (EGFRv3))
- Autre désignation
- EGFRVIII (EGFRv3 Produits)
- Sujet
- The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements, with the most common extracellular domain mutation being EGFRvIII. This mutation leads to a deletion of exons 2-7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand.
- Poids moléculaire
- 41.6 kDa.
- NCBI Accession
- NP_001333870
-